Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-309.73%
operating margin TTM
-346.08%
revenue TTM
40.62 Million
revenue per share TTM
0.38$
valuation ratios | |
|---|---|
| pe ratio | -1.68 |
| peg ratio | 0.99 |
| price to book ratio | 1.10 |
| price to sales ratio | 5.17 |
| enterprise value multiple | -1.75 |
| price fair value | 1.10 |
profitability ratios | |
|---|---|
| gross profit margin | 97.01% |
| operating profit margin | -346.08% |
| pretax profit margin | -309.23% |
| net profit margin | -309.73% |
| return on assets | -41.17% |
| return on equity | -55.4% |
| return on capital employed | -52.31% |
liquidity ratio | |
|---|---|
| current ratio | 6.98 |
| quick ratio | 6.98 |
| cash ratio | 1.82 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 464.89 |
| cash conversion cycle | -464.89 |
| receivables turnover | 0.00 |
| payables turnover | 0.79 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.12 |
| debt equity ratio | 0.18 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.15 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -3.60 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.21 |
| cash per share | 2.36 |
| operating cash flow per share | -1.20 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -3.60 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -174.40 |
Frequently Asked Questions
When was the last time Tango Therapeutics, Inc. (NASDAQ:TNGX) reported earnings?
Tango Therapeutics, Inc. (TNGX) published its most recent earnings results on 06-11-2024.
What is Tango Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Tango Therapeutics, Inc. (NASDAQ:TNGX)'s trailing twelve months ROE is -55.4%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Tango Therapeutics, Inc. (TNGX) currently has a ROA of -41.17%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TNGX's net profit margin stand at?
TNGX reported a profit margin of -309.73% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TNGX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.98 in the most recent quarter. The quick ratio stood at 6.98, with a Debt/Eq ratio of 0.18.